Cordis

Cordis is a global provider of vascular interventional medical devices. Cordis joined Cardinal Health in 2015, and this powerful alliance has enabled it to better assist patients in combating vascular diseases on a global scale.Cordis has achieved numerous "industry firsts" in the global field of vascular intervention, continuously delivering innovative results to healthcare professionals worldwide and gaining widespread recognition in the industry. It is one of the leaders in the cardiac and peripheral vascular fields. The world's first Judkins catheter was created by Cordis. As early as 1966, Cordis introduced the first guiding catheter, and in the following decades, Cordis created multiple "firsts" in vascular interventional procedures: the first full-line pre-shaped catheter — the Judkins catheter, the first vascular sheath with a hemostatic valve, the first self-expanding stent made of nickel-titanium alloy — S.M.A.R.T., and the first coronary drug-eluting stent, Cypher. These "firsts" have established Cordis' pioneering position.Cordis has grown alongside the development of interventional treatment in China, playing a very important role in the popularization of industry knowledge, including academic sharing, hands-on assistance, talent cultivation, department establishment, patient education, and the establishment of industry standards.